Five years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension September 28, 2020 Share Get link Facebook X Pinterest Email Other Apps Labels AAN Neurology recent issues Share Get link Facebook X Pinterest Email Other Apps Comments
Comments
Post a Comment